The time of trials: Waiting for a coronavirus vaccine

An infected and impatient world needs protection from Covid-19, but rushing it won’t be easy. How can we speed up a complicated process?

(22 May 2020, feed from Knowable Magazine

The Covid-19 coronavirus has knocked our world off its axis. We won’t return to anything approaching normal — that is, life without social distancing, quarantines, masks, school closures and other control measures — until most of the world has been vaccinated against the virus. Everyone, therefore, has the same question on their mind: How fast will a vaccine be ready?

These are not normal times, however, and a vaccine for the Covid-19 virus, formally known as SARS-CoV-2, is the focus of unprecedented research efforts. Already, over 100 research groups have vaccine candidates under development, and a few are already being tested in people. In mid-May, the US government announced “Operation Warp Speed,” an initiative that aims to have a vaccine ready for general use by the end of 2020.

Almost all experts say that target is too optimistic, generally citing the spring of 2021 as a best-case scenario. But to hit even that later target, a lot of things have to break right, and a lot of logistic hurdles have to be cleared away. Here’s a look at some of the key issues in vaccine development.

Read the full story from Knowable Magazine here.

 

LibraryLearningSpace.com is now collaborating with Knowable Magazine to bring you the latest research stories of the real-world significance of scholarly work through a journalistic lens.